US Stock MarketDetailed Quotes

PRQR ProQR Therapeutics

Watchlist

2.4200
-0.2000-7.63%

Close Jan 10 16:00 ET

2.4200
0.00000.00%

Post 16:00 ET

256.29MMarket Cap-7.83P/E (TTM)

ProQR Therapeutics News

News

Announcement

Ratings

All

Earnings

Transactions

Shareholding

Events

Other

ProQR Therapeutics | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)
Dec 12, 2024 21:26
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 12, 2024 05:05
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 11, 2024 20:19
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 10, 2024 21:09
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 5, 2024 21:09
ProQR Therapeutics | F-3: Registration statement for specified transactions by certain foreign private issuers
Oct 1, 2024 05:09
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
May 23, 2024 04:22
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
May 8, 2024 20:13
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 23, 2024 19:09
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 19, 2024 19:08
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 13, 2024 19:13
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 15, 2024 20:52
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 19, 2024 13:00
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 5, 2024 13:00
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 8, 2023 20:37
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Sep 27, 2023 19:06
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aug 1, 2023 19:15
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
May 18, 2023 04:05
ProQR Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 18, 2023 20:05
ProQR Therapeutics | F-3: Registration statement for specified transactions by certain foreign private issuers
Mar 30, 2023 04:53

US

Overall

No Data